EarliPoint
Pediatric Autism Spectrum Disorder Diagnosis Aid. 510(k) K230337, from Earlitec Diagnostics, Inc. (Atlanta, GA). Product code QPF, class 2.
As of Nov 21, 2026, K230337 is an FDA 510(k) held by Earlitec Diagnostics, Inc., substantially equivalent on Jun 29, 2023 after 142 days, with no recalls tied to it in FDA's recall database.
- Review time: 142 days
- Recalls: 0
- Cited as a predicate by: 1 device
The EarliPoint System is indicated for use in specialized developmental disabilities centers as a tool to aid clinicians in the diagnosis and assessment of ASD patients ages 16 months through 30 months
- EarliPoint SystemK213882 · Earlitec Diagnostics, Inc. · Jun 8, 2022
- EarliPoint SystemK243891 · Earlitec Diagnostics · Mar 26, 2025
- NeuroraK260064 · Argus Cognitive, Inc. · Oct 2, 2026
- EarliPoint AssessmentK253442 · Earlitec Diagnostics · Mar 5, 2026
- Canvas DxK243558 · Cognoa, Inc. · Apr 11, 2025
- EarliPoint SystemK243891 · Earlitec Diagnostics · Mar 26, 2025
- EarliPoint SystemK213882 · Earlitec Diagnostics, Inc. · Jun 8, 2022
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 7, 2023
- Review panel
- Neurology
- Regulation
- 21 CFR 882.1491
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files